Head of tumor immunolgy Unit
Cancer Gustave Rousssy Institute
Dr. Salem Chouaib completed his undergraduate studies at the university of Pierre and Marie Curie (Paris VI) at Pasteur Institute. He received his Doctorat es-sciences (Ph.D.) in immunology, (laboratory of Jean Dausset, Nobel prize in medicine) in 1983 from the same university. He then joined the Memorial Sloan Kettering Cancer Center in New York where he undertook a post-doctoral training in Human Immnogenetics Laboratory. In 1986, he was appointed as research associate at the French National Institute of Health and Biomedical Research (INSERM) and joined the tumor biology department at the Institut Gustave Roussy. At present he is research director and is heading the INSERM research unit 753 (Human Cancer Immunology and Immunotherapy). Dr Chouaib’s laboratory currently focuses on the investigation of the functional cross talk between cytotoxic cells and tumor targets in the context of tumor microenvironment complexity and plasticity. Dr Chouaib research was constantly directed at impulsing the transfer of fundamental concepts in clinical application in particular in the field of cancer vaccine and cancer immunotherapy. He was awarded the cancer research prize of the French ligue against cancer in 1992 and in 2004 the presidential prize in biotechnology. He is lecturing tumor immunology for the PhD programs at the University Paris Sud. His research resulted in more than 220 scientific articles and several reviews in the field of human immunology and tumor biology as well as in editorship for contribution to several books. Furthermore he is guest lecturer at different universities. He is ad hoc referee for numerous journals and scientific foundations. He is a member of various professional associations and is scientific advisor and consultant in many scientific institutions.
Cell-mediated cytotoxicity, tumor microenvironment, immunology and immunotherapy of cancer.